Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02967744
Other study ID # N-20140077
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2016
Est. completion date February 1, 2018

Study information

Verified date February 2024
Source Aalborg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study investigates associations between pre treatment pain intensity and central pain mechanisms on the effect of 8-week treatment of NSAIDs in patients with knee osteoarthritis.


Recruitment information / eligibility

Status Completed
Enrollment 162
Est. completion date February 1, 2018
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Diagnosed Knee Ostoarthritis Exclusion Criteria: - Current ulcer diagnosed by endoscope - Asthma or other allergic reaction to NSIADs - Kidney disease - Myocardial infarction within the last six months - Severe hyper tension (systolic =180mmHg, diastolic =110mmHg) - Severe thrombocytopenia (thrombocyst count <50x10^9/l) - Insufficience lever or kidney function

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
NSAID
NSAIDs are among the most common pain treatments for patients with osteoarthritis.

Locations

Country Name City State
Denmark Center for Sensory Motor Interaction, Aalborg University Aalborg East

Sponsors (1)

Lead Sponsor Collaborator
Aalborg University

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain intensity measured on a 10cm visual analog scale Patients will be asked to rate the pain intensity 8 weeks after treatment on a 10cm visual analog scale (0 indicating no pain, 10 indicating worst imaginable pain 8 weeks after treatment
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02784041 - Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty N/A
Completed NCT02966613 - Fully Disposable Patient-Specific Instrumentation N/A
Recruiting NCT03074994 - The Comparative Efficacy of Peri-articular and Intraarticular Tranexamic Acid in Total Knee Arthroplasty Phase 2
Completed NCT00137410 - Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee Phase 3
Recruiting NCT03360500 - Cryotherapy Associated With Exercise in Pain Control and Physical Function in Individuals With Knee Osteoarthritis N/A
Completed NCT02967874 - Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment Phase 1/Phase 2
Completed NCT01899417 - Costs and Benefits of ConforMIS iTotal® Knee Replacement System Versus Standard Total Knee
Completed NCT01042093 - Efficacy of Multimodal Perioperative Analgesia With Periarticular Drug Injection in Total Knee Arthroplasty(TKA) N/A
Completed NCT03033238 - Multicenter Bone and Joint Health Study
Completed NCT03011112 - Can 3D Kinematic Parameters Assess the Symptomatic and Functional Severity of KOA? N/A
Completed NCT02975154 - Microcurrent Therapy in the Treatment of Osteoarthritis of the Knee N/A
Completed NCT03684850 - Knee Brace and Biomechanical Footwear in the Treatment of Knee Osteoarthritis. N/A
Completed NCT03007576 - Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem) Phase 1